[1]CurrentPatentAssignee:MASSGENERALBRIGHAMINC;HARVARDUNIVERSITY;BROADINSTITUTE;BAYERAG-WO2018/77923,2018,A1Locationinpatent:Page/Pagecolumn371-372
[2]CurrentPatentAssignee:BROADINSTITUTE;BAYERAG-US2019/307728,2019,A1Locationinpatent:Paragraph0241-0244
[3]CurrentPatentAssignee:BAYERAG-WO2019/197269,2019,A1Locationinpatent:Page/Pagecolumn61
[4]CurrentPatentAssignee:BAYERAG-EP3553052,2019,A1Locationinpatent:Paragraph0189-0190
[1]CurrentPatentAssignee:BROADINSTITUTE;BAYERAG-US2019/307728,2019,A1
[2]CurrentPatentAssignee:BAYERAG-WO2019/197269,2019,A1
[3]CurrentPatentAssignee:BAYERAG-EP3553052,2019,A1
[1]Patent:US2019/307728,2019,A1
[2]Patent:WO2019/197269,2019,A1
[3]Patent:EP3553052,2019,A1
[1]CurrentPatentAssignee:BROADINSTITUTE;BAYERAG-US2019/307728,2019,A1
[2]CurrentPatentAssignee:BAYERAG-WO2019/197269,2019,A1
[3]CurrentPatentAssignee:BAYERAG-EP3553052,2019,A1
[1]CurrentPatentAssignee:BAYERAG-WO2019/197239,2019,A1Locationinpatent:Page/Pagecolumn96-97
Title: Andreas Janzer, et al. Abstract DDT02-04: BAY 2402234: A novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of myeloid malignancies. AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL.